Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial

FSC Melo, GCG Leal, MS Carvalho, APJ Nunes… - 2018 - arca.fiocruz.br
… aspartate antagonist in treatment-resistant major depression. Arch Gen … Antidepressant
efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial

Antidepressant efficacy and tolerability of ketamine and esketamine: a critical review

P Molero, JA Ramos-Quiroga, R Martin-Santos… - CNS drugs, 2018 - Springer
… onset antidepressant effect in treatment-resistant depression. … of major depressive disorder
(MDD) and bipolar depression … , randomized, placebo-controlled trial evaluating the efficacy

[HTML][HTML] … integrative approach to ketamine therapy may enhance multiple dimensions of efficacy: improving therapeutic outcomes with treatment resistant depression

SA Muscat, G Hartelius, CR Crouch… - Frontiers in Psychiatry, 2021 - frontiersin.org
… of treatment resistant major depressive disorder received one … of the antidepressant
effectiveness of ketamine. This theory … studies, of which 60 were included: 20 randomized control

Efficacy of intravenous racemic ketamine and intranasal esketamine with dose escalation for treatment-resistant depression: A systematic review and meta-analysis

A Seshadri, L Prokop, B Singh - Journal of Affective Disorders, 2024 - Elsevier
… rapid antidepressant effects in treatment-resistant depression(… We included randomized
controlled trials (RCTs) with … /treatment-resistant major depression/treatment-resistant bipolar …

Adjunctive intranasal esketamine for major depressive disorder: a systematic review of randomized double-blind controlled-placebo studies

W Zheng, DB Cai, YQ Xiang, WL Jiang, K Sim… - Journal of Affective …, 2020 - Elsevier
… However, ketamine in the treatment of depression required … Efficacy of esketamine nasal
spray plus oral antidepressanttreatment-resistant depression: a randomized clinical trial

Ketamine and Transcranial Magnetic Stimulation in an Adolescent with Treatment-Resistant Depression

AU Jerath, SE Oldak, MS Parrish, M Zaydlin… - Journal of Child and …, 2023 - liebertpub.com
Antidepressant efficacy of ketamine in treatment-resistant major depression: A two-site
randomized controlled trial… Comparison of long-term efficacy and safety of esketamine nasal spray …

Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression

NC Salloum, M Fava, RS Hock, MP Freeman… - Journal of affective …, 2020 - Elsevier
randomized controlled trials (RCT) confirming the acute and robust antidepressant effect of
a single infusion of ketamine … of Ketamine plus Scopolamine in major depressive disorder (…

A comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depression

A Tamman, A Anand, SJ Mathew - Expert Opinion on Drug Safety, 2022 - Taylor & Francis
… trajectory of depression, as severe depression often emerges in … Of the controlled studies
that have been done, cases of … If the ongoing RECOVER randomized controlled blinded trial […

[PDF][PDF] Combination therapy with transcranial magnetic stimulation and ketamine for treatment-resistant depression: a long-term retrospective review of clinical use

SRD Best, DG Pavel, N Haustrup - Heliyon, 2019 - cell.com
Treatment-resistant depression refers to a major depressive disorder (MDD) with a lack
of … treatment responsiveness of these patients is provided by the antidepressant treatment …

[HTML][HTML] Ketamine in major depressive disorder: mechanisms and future perspectives

C Shin, YK Kim - Psychiatry investigation, 2020 - ncbi.nlm.nih.gov
… A series of recent randomized controlled trials have provided … may be required to maintain
antidepressant efficacy. Moreover, … treatment-resistant depression: a randomized clinical trial. …